H-Ala-D-Glu(Lys-D-Ala-D-Ala-OH)-OH features a branched arrangement that supports examining steric constraints and hydrogen-bond patterns. Its sequence allows modeling of chiral residue effects on folding. Researchers evaluate conformational preferences for structural-analog development. The molecule aids synthetic-peptide engineering.
CAT No: D1202
CAS No:2614-55-3
Synonyms/Alias:2614-55-3;H-Ala-D-Glu(Lys-D-Ala-D-Ala-OH)-OH;Ala-D-gamma-Glu-Lys-D-Ala-D-Ala;(2R,5R,8S,13R,16S)-16-Amino-8-(4-aminobutyl)-13-carboxy-2,5-dimethyl-4,7,10,15-tetraoxo-3,6,9,14-tetraazaheptadecan-1-oic acid;Ala-D-|A-Glu-Lys-D-Ala-D-Ala;SCHEMBL1573989;HY-P5919;L-Ala-D-gamma-Glu-L-Lys-D-Ala-D-Ala;DA-73997;FA108667;CS-0896315;G85479;D-Alanine, L-alanyl-D-gamma-glutamyl-L-lysyl-D-alanyl-;(2R)-5-[[(2S)-6-amino-1-[[(2R)-1-[[(1R)-1-carboxyethyl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-2-[[(2S)-2-aminopropanoyl]amino]-5-oxopentanoic acid;(2R,5R,8S,13R,16S)-16-Amino-8-(4-aminobutyl)-13-carboxy-2,5-dimethyl-4,7,10,15-tetraoxo-3,6,9,14-tetraazaheptadecan-1-oicacid;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More